Advantage--FK 506: reduced chronic rejection for lung transplant recipients.
Bolman
R M
RM
D001989:Bronchiolitis Obliterans / Q000517:prevention & control; D002908:Chronic Disease; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D016040:Lung Transplantation / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
D016572:Cyclosporine; D016559:Tacrolimus